Hasan Jafri - 18 Sep 2023 Form 4 Insider Report for Aridis Pharmaceuticals, Inc.

Role
Chief Medical Officer
Signature
/s/ Hasan Jafri
Issuer symbol
N/A
Transactions as of
18 Sep 2023
Net transactions value
$0
Form type
4
Filing time
19 Sep 2023, 16:05:21 UTC
Previous filing
15 Jun 2023
Next filing
28 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDS Stock Options Award $0 +20,000 +13% $0.000000 175,000 18 Sep 2023 Common Stock 20,000 $0.0800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the options vest on the date of grant and approximately 1,666 vest on a monthly basis thereafter for six months.